Cytokinetics

Related records

Trials (46)

• A Pharmacokinetic and Pharmacodynamic Study of Omecamtiv Mecarbil in Healthy Volunteers
• A Phase 3, Open-Label Extension of COURAGE-ALS (CY 5031)
• A Single and Multiple Ascending Dose Study of CK-3773274 in Healthy Adult Subjects
• A Single and Multiple Ascending Dose Study of CK-3828136 in Healthy Adult Participants
• A Single and Multiple Ascending Dose Study of CK-4021586 in Healthy Adult Participants
• A Study for Patients Who Completed VITALITY-ALS (CY 4031)
• A Study of CK-1827452 Infusion in Stable Heart Failure
• A Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)
• A Study of CK-2017357 in Patients With Peripheral Artery Disease and Symptomatic Claudication
• A Study of CK-2127107 in Patients With Spinal Muscular Atrophy
• A Study of Ispinesib in Metastatic Breast Cancer
• A Study of SB-743921 in Non-Hodgkin Lymphoma and Hodgkin Lymphoma
• A Study to Assess the Anti-fatigability Effect of CK-2127107 in Elderly Male and Female Subjects With Limitations in Mobility
• A Study to Assess the Effect of CK-2127107 on Physical Function in Subjects With Chronic Obstructive Pulmonary Disease
• A Study to Evaluate Efficacy, Safety and Tolerability of CK-2127107 in Patients With Amyotrophic Lateral Sclerosis (ALS)
• A Study to Evaluate the Effect of Aficamten in Pediatric Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM).
• A Study to Evaluate the Effects of Multiple Doses of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)
• A Study to Evaluate the Efficacy and Safety of Reldesemtiv in Patients With Amyotrophic Lateral Sclerosis (ALS)
• A Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM)
• AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF